Showing results 1 to 9 of 9
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis Journal:Journal of Hepatology | 2022 | |||
Chronic hepatitis B: Virology, natural history, current management and a glimpse at future opportunities Journal:Antiviral Research | 2015 | 100 | ||
14-Oct-2022 | ||||
2021 | 16 | |||
2021 | 7 | |||
2020 | 20 | |||
RNAi-based treatment of chronically infected patients and chimpanzees reveals that integrated hepatitis B virus DNA is a source of HBsAg Journal:Science Translational Medicine | 2017 | 32 | ||
Safety, Tolerability, and Pharmacokinetics of ARC-520 Injection, an RNA Interference-Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers Journal:Clinical Pharmacology in Drug Development | 2017 | 51 | ||
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent Journal:Antiviral Research | 2015 |